Abstract:Sarcoidosis is an inflammatory granulomatous disease of unknown etiology involving any organ or tissue along with any combination of active sites, even the most silent ones clinically. The unpredictable nature of the sites involved in sarcoidosis dictates the highly variable natural history of the disease and the necessity to cluster cases at diagnosis based on clinical and/or imaging common characteristics in an attempt to classify patients based on their more homogeneous phenotypes, possibly with similar clinical behavior, prognosis, outcome, and therefore with therapeutic requirements. In the course of the disease's history, this attempt relates to the availability of a means of detection of the sites involved, from the Karl Wurm and Guy Scadding's chest x-ray staging through the ACCESS, the WASOG Sarcoidosis Organ Assessment Instruments, and the GenPhenReSa study to the 18 F-FDG PET/CT scan phenotyping and far beyond to new technologies and/or the current “omics.” The hybrid molecular imaging of the 18 F-FDG PET/CT scan, by unveiling the glucose metabolism of inflammatory cells, can identify high sensitivity inflammatory active granulomas, the hallmark of sarcoidosis—even in clinically and physiologically silent sites—and, as recently shown, is successful in identifying an unexpected ordered stratification into four phenotypes: (I) hilar–mediastinal nodal, (II) lungs and hilar–mediastinal nodal, (III) an extended nodal supraclavicular, thoracic, abdominal, inguinal, and (IV) all the above in addition to systemic organs and tissues, which is therefore the ideal phenotyping instrument. During the “omics era,” studies could provide significant, distinct, and exclusive insights into sarcoidosis phenotypes linking clinical, laboratory, imaging, and histologic characteristics with molecular signatures. In this context, the personalization of treatment for sarcoidosis patients might have reached its goal.

Imaging of Pulmonary Sarcoidosis—A Review

Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis

S4353 Imaging of Sarcoidosis With Pulmonary, Hepatic, and Splenic Involvement: Diagnostic Challenges

Role of Bronchoscopy in Diagnosis of Sarcoidosis

Imaging of Cardiac Sarcoidosis: An Update and Future Aspects

Etanercept for Sleep in Patients with Alcohol Use Disorder—Mechanisms Need to be Elucidated

FDG PET/CT Imaging of Sarcoidosis.

Recent advances in sarcoidosis

Molecular Mechanism in the Development of Pulmonary Fibrosis in Patients with Sarcoidosis

Cystic lung in sarcoidosis: Clinico‐radiologic characteristic and evolution

High-Risk Sarcoidosis: A Focus on Pulmonary, Cardiac, Hepatic and Renal Advanced Diseases, as Well as on Calcium Metabolism Abnormalities

[Genetic risk factor for the onset and progression of diabetic complication].

From Karl Wurm and Guy Scadding's staging to 18F-FDG PET/CT scan phenotyping and far beyond: perspective in the evading history of phenotyping in sarcoidosis

Putative structure of the FGF6 gene product and role of the signal peptide.

Gastrointestinal Manifestations of Sarcoidosis: A State-of-the-Art, Comprehensive Review of the Literature—Practical Clinical Insights and Many Unmet Needs on Diagnosis and Treatment

Phenotypes and Serum Biomarkers in Sarcoidosis

An Atypical Presentation of Sarcoidosis

Clinical and radiological resolution of vertebral sarcoidosis mimicking metastatic disease

Diagnosis of pulmonary sarcoidosis comorbid with non-specific interstitial pneumonia: a case report

Contemporary Diagnostics of Cardiac Sarcoidosis: The Importance of Multimodality Imaging

S4419 Sarcoidosis Revealed: Granulomas Uncovered in the Search for a Suspected Tropical Infection